• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国急性内科疾病住院患者的住院时长对预防频率及静脉血栓栓塞风险的影响。

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA.

作者信息

Amin Alpesh, Neuman W Richey, Lingohr-Smith Melissa, Menges Brandy, Lin Jay

机构信息

Univeristy of California, Irvine, School of Medicine, Irvine, CA, USA.

Portola Pharmaceuticals, South San Francisco, CA, USA.

出版信息

Drugs Context. 2019 Jan 21;8:212568. doi: 10.7573/dic.212568. eCollection 2019.

DOI:10.7573/dic.212568
PMID:30719052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6344107/
Abstract

BACKGROUND

We evaluated whether the duration of hospital stay influences venous thromboembolism (VTE) prophylaxis patterns and VTE risk during hospitalization and post-discharge among patients hospitalized for acute illnesses in the USA.

METHODS

Patients hospitalized for acute illnesses were identified from the US MarketScan Commercial and Medicare databases (January 1, 2012-June 30, 2015). Patients were stratified by index hospital length of stay (LOS), with study groups with 1-3 day, 4-6 day, and ≥7 day LOSs. Use of VTE prophylaxis and VTE event rates during and after hospitalization (6-month follow-up) were evaluated.

RESULTS

Of the overall population, 8647 had a 1-3 day LOS, 5551 had a 4-6 day LOS, and 3697 had a ≥7 day LOS. A greater proportion of patients with a 1-3 day LOS (66.2%) did not receive any VTE prophylaxis in comparison to patients with a 4-6 day LOS (55.0%) and ≥7 day LOS (48.8%; <0.001). Proportions of patients with VTE events during the index hospitalization increased with longer hospital LOS (1-3 day LOS: 0.5%; 4-6 day LOS: 1.3%; ≥7 day LOS: 5.4%), as did proportions of patients with VTE events during the 6-month follow-up (1-3 day LOS: 2.4%; 4-6 day LOS: 2.7%; ≥7 day LOS: 4.2%).

CONCLUSION

Among this study population of hospitalized acutely ill patients in the USA, VTE pharmacologic prophylaxis was underutilized, regardless of the duration of hospital stay. However, the risk for VTE events was substantial, with nearly 10% of those with a ≥7 day LOS having suffered a VTE event within 6 months.

摘要

背景

我们评估了住院时间长短是否会影响美国因急性疾病住院患者在住院期间及出院后的静脉血栓栓塞症(VTE)预防模式和VTE风险。

方法

从美国市场扫描商业和医疗保险数据库(2012年1月1日至2015年6月30日)中识别出因急性疾病住院的患者。患者按首次住院时长(LOS)分层,分为住院时长为1 - 3天、4 - 6天和≥7天的研究组。评估住院期间及出院后(6个月随访)VTE预防措施的使用情况和VTE事件发生率。

结果

在总体人群中,8647人住院时长为1 - 3天,5551人住院时长为4 - 6天,3697人住院时长≥7天。与住院时长为4 - 6天(55.0%)和≥7天(48.8%)的患者相比,住院时长为1 - 3天的患者中未接受任何VTE预防措施的比例更高(66.2%;<0.001)。首次住院期间发生VTE事件的患者比例随住院时长增加而升高(1 - 3天住院时长组:0.5%;4 - 6天住院时长组:1.3%;≥7天住院时长组:5.4%),6个月随访期间发生VTE事件的患者比例也是如此(1 - 3天住院时长组:2.4%;4 - 6天住院时长组:2.7%;≥7天住院时长组:4.2%)。

结论

在美国该急性病住院患者研究人群中,无论住院时间长短,VTE药物预防措施的使用均不足。然而,VTE事件风险很高,住院时长≥7天的患者中近10%在6个月内发生了VTE事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d58/6344107/af9fe532f19e/dic-8-212568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d58/6344107/1fe3d33bfa20/dic-8-212568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d58/6344107/af9fe532f19e/dic-8-212568-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d58/6344107/1fe3d33bfa20/dic-8-212568-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d58/6344107/af9fe532f19e/dic-8-212568-g002.jpg

相似文献

1
Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA.美国急性内科疾病住院患者的住院时长对预防频率及静脉血栓栓塞风险的影响。
Drugs Context. 2019 Jan 21;8:212568. doi: 10.7573/dic.212568. eCollection 2019.
2
Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.美国住院急性病患者住院和门诊连续护理中的静脉血栓栓塞预防和风险:一项回顾性分析。
Adv Ther. 2019 Jan;36(1):59-71. doi: 10.1007/s12325-018-0846-2. Epub 2018 Dec 12.
3
Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.美国急性内科疾病患者静脉血栓栓塞症再入院的频率及其相关的住院费用和住院时间。
J Med Econ. 2019 Nov;22(11):1119-1125. doi: 10.1080/13696998.2019.1618862. Epub 2019 Jun 4.
4
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.内科疾病患者的静脉血栓栓塞症延伸预防:NATF 抗凝行动倡议。
Am J Med. 2020 May;133 Suppl 1:1-27. doi: 10.1016/j.amjmed.2019.12.001.
5
Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.医院在药物预防静脉血栓栓塞症方面的表现和静脉血栓栓塞症的发生率:一项队列研究。
JAMA Intern Med. 2014 Oct;174(10):1577-84. doi: 10.1001/jamainternmed.2014.3384.
6
Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status.静脉血栓栓塞预防与不同年龄和肾脏疾病状态的急性重病患者的风险分层。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618823287. doi: 10.1177/1076029618823287.
7
Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.心力衰竭住院老年患者的静脉血栓栓塞症药物预防和 30 天结局:来自 ADHERE 国家登记处与医疗保险索赔链接的分析。
Clin Cardiol. 2011 Nov;34(11):682-8. doi: 10.1002/clc.20986. Epub 2011 Nov 6.
8
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.加拿大急性病内科患者静脉血栓栓塞预防措施使用情况的多中心评估。
Thromb Res. 2007;119(2):145-55. doi: 10.1016/j.thromres.2006.01.011. Epub 2006 Mar 3.
9
Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients.患有内科疾病的住院患者静脉血栓栓塞风险的连续变化过程。
J Hosp Med. 2012 Mar;7(3):231-8. doi: 10.1002/jhm.1002. Epub 2011 Dec 21.
10
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.急性病住院内科患者的静脉血栓栓塞预防:国际静脉血栓栓塞医学预防登记研究的结果
Chest. 2007 Sep;132(3):936-45. doi: 10.1378/chest.06-2993. Epub 2007 Jun 15.

引用本文的文献

1
Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 2025.埃塞俄比亚的深静脉血栓形成:一项系统评价和荟萃分析,2025年。
Thromb J. 2025 Jun 20;23(1):68. doi: 10.1186/s12959-025-00760-6.
2
Risk Factors of In-Hospital Venous Thromboembolism and Prognosis After Emergent Ventral Hernia Repair.急诊腹疝修补术后院内静脉血栓栓塞的危险因素及预后
Emerg Med Int. 2024 Nov 12;2024:6670898. doi: 10.1155/2024/6670898. eCollection 2024.
3
Impact of Clinical Decision Support with Mandatory versus Voluntary Venous Thromboembolism Risk Assessment in Hospitalized Patients.

本文引用的文献

1
Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.美国住院急性病患者住院和门诊连续护理中的静脉血栓栓塞预防和风险:一项回顾性分析。
Adv Ther. 2019 Jan;36(1):59-71. doi: 10.1007/s12325-018-0846-2. Epub 2018 Dec 12.
2
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).延长疗程的贝曲西班降低急性病住院内科患者静脉血栓栓塞相关再住院风险:APEX试验(使用延长疗程贝曲西班预防急性内科疾病患者静脉血栓栓塞试验)的结果
Circulation. 2018 Jan 2;137(1):91-94. doi: 10.1161/CIRCULATIONAHA.117.031187.
3
住院患者中强制性与自愿性静脉血栓栓塞风险评估的临床决策支持影响
TH Open. 2024 Sep 12;8(3):e317-e328. doi: 10.1055/s-0044-1790519. eCollection 2024 Jul.
4
Factors Associated with Hospital Length of Stay among VTE Cases: Insights from the i-RegVed Registry.静脉血栓栓塞症病例住院时间的相关因素:来自 i-RegVed 登记处的见解。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241266815. doi: 10.1177/21501319241266815.
5
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.美国2019冠状病毒病相关肺曲霉病的发病率及住院治疗结果
Ann Thorac Med. 2024 Jan-Mar;19(1):87-95. doi: 10.4103/atm.atm_190_23. Epub 2024 Jan 25.
6
Exploring the Clinical Efficacy of Venous Thromboembolism Management in Saudi Arabian Hospitals: An Insight into Patient Outcomes.探索沙特阿拉伯医院静脉血栓栓塞管理的临床疗效:对患者预后的洞察
J Pers Med. 2023 Mar 31;13(4):612. doi: 10.3390/jpm13040612.
7
Trends in Venous Thromboembolism Readmission Rates after Ischemic Stroke and Intracerebral Hemorrhage.缺血性卒中和脑出血后静脉血栓栓塞再入院率的趋势
J Stroke. 2023 Jan;25(1):151-159. doi: 10.5853/jos.2022.02215. Epub 2023 Jan 3.
8
Delayed Initiation of Rescue Therapy Associated with Increased Length of Stay in Acute Severe Ulcerative Colitis.延迟启动挽救性治疗与急性重度溃疡性结肠炎住院时间延长相关。
Dig Dis Sci. 2022 Dec;67(12):5455-5461. doi: 10.1007/s10620-022-07490-z. Epub 2022 Apr 7.
9
Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode.重度抑郁发作的住院患者中,抑郁症状的严重程度与静脉血栓栓塞相关。
Neuropsychiatr Dis Treat. 2021 Sep 21;17:2955-2963. doi: 10.2147/NDT.S331409. eCollection 2021.
10
Post-acute care management of a patient with COVID-19 using remote cardiorespiratory monitoring.使用远程心肺监测对新冠病毒疾病患者进行急性后期护理管理。
Respir Med Case Rep. 2021;33:101436. doi: 10.1016/j.rmcr.2021.101436. Epub 2021 Jun 15.
Significant reduction in hospital-acquired thrombosis: impact of national risk assessment and real-time feedback.医院获得性血栓形成显著减少:国家风险评估和实时反馈的影响
Open Heart. 2017 Sep 28;4(2):e000653. doi: 10.1136/openhrt-2017-000653. eCollection 2017.
4
New paradigms in venous thromboprophylaxis of medically ill patients.医学疾病患者静脉血栓栓塞症预防的新理念。
Thromb Haemost. 2017 Aug 30;117(9):1662-1670. doi: 10.1160/TH17-03-0168. Epub 2017 Jun 22.
5
Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US.一种近乎普遍的基于住院治疗的预防方案对美国每年静脉血栓栓塞事件数量的影响。
Blood. 2017 Jul 13;130(2):109-114. doi: 10.1182/blood-2016-12-758995. Epub 2017 May 8.
6
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.急性病医学患者贝曲西班的延长血栓预防。
N Engl J Med. 2016 Aug 11;375(6):534-44. doi: 10.1056/NEJMoa1601747. Epub 2016 May 27.
7
Prior thromboprophylaxis and outcome in patients experiencing acute venous thromboembolism after an acute medical illness.急性内科疾病后发生急性静脉血栓栓塞症患者的既往血栓预防和结局。
Eur J Intern Med. 2016 May;30:72-76. doi: 10.1016/j.ejim.2016.02.022. Epub 2016 Mar 11.
8
Costs of venous thromboembolism associated with hospitalization for medical illness.与内科疾病住院相关的静脉血栓栓塞症的费用。
Am J Manag Care. 2015 Apr 1;21(4):e255-63.
9
Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.医院在药物预防静脉血栓栓塞症方面的表现和静脉血栓栓塞症的发生率:一项队列研究。
JAMA Intern Med. 2014 Oct;174(10):1577-84. doi: 10.1001/jamainternmed.2014.3384.
10
Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target.与住院相关的致命静脉血栓栓塞症:一项评估国家风险评估目标影响的队列研究。
Heart. 2013 Dec;99(23):1734-9. doi: 10.1136/heartjnl-2013-304479. Epub 2013 Sep 15.